BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2557879)

  • 1. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
    Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
    Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
    Haglund C; Lindgren J; Roberts PJ; Nordling S
    Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
    Haglund C; Lindgren J; Roberts PJ; Nordling S
    Br J Cancer; 1986 Feb; 53(2):189-95. PubMed ID: 3513813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.
    Makovitzky J
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
    Schwenk J; Makovitzky J
    Int J Pancreatol; 1989 Jul; 5(1):85-98. PubMed ID: 2746048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of C-242 antigen in pancreatic ductal adenocarcinoma.
    Mäkinen K; Eskelinen M; Lipponen P; Alhava E
    Anticancer Res; 1995; 15(4):1605-8. PubMed ID: 7654056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on the expression of gastrointestinal-cancer-associated antigen, PA8-15, CA19-9 and the blood-group antigens in non-malignant and malignant human pancreatic tissues.
    Egami H; Sakamoto K; Yoshimura R; Arai M; Takiyama Y; Pour PM
    J Cancer Res Clin Oncol; 1990; 116(4):365-71. PubMed ID: 2391357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lex and Ley antigen expression in human pancreatic cancer.
    Kim YS; Itzkowitz SH; Yuan M; Chung Y; Satake K; Umeyama K; Hakomori S
    Cancer Res; 1988 Jan; 48(2):475-82. PubMed ID: 3335015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-histochemical investigations with monoclonal antibodies against CEA-related components in chronic pancreatitis and pancreatic carcinoma.
    Makovitzky J
    Hepatogastroenterology; 1987 Feb; 34(1):31-5. PubMed ID: 2437000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
    Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
    Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias.
    Bätge B; Bosslet K; Sedlacek HH; Kern HF; Klöppel G
    Virchows Arch A Pathol Anat Histopathol; 1986; 408(4):361-74. PubMed ID: 3004013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
    Blind PJ; Dahlgren ST
    Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
    Haglund C; Lindgren J; Roberts PJ; Nordling S
    Br J Cancer; 1991 Mar; 63(3):386-9. PubMed ID: 1848439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis.
    Malesci A; Tommasini MA; Bonato C; Bocchia P; Bersani M; Zerbi A; Beretta E; Di Carlo V
    Gastroenterology; 1987 Jan; 92(1):60-7. PubMed ID: 3465666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
    Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
    Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Tn, sialosyl Tn, and T antigens in human pancreas.
    Itzkowitz S; Kjeldsen T; Friera A; Hakomori S; Yang US; Kim YS
    Gastroenterology; 1991 Jun; 100(6):1691-700. PubMed ID: 1850375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues.
    Satomura Y; Sawabu N; Takemori Y; Ohta H; Watanabe H; Okai T; Watanabe K; Matsuno H; Konishi F
    Pancreas; 1991 Jul; 6(4):448-58. PubMed ID: 1678888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue.
    Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
    Int J Pancreatol; 1987; 2(5-6):349-60. PubMed ID: 3320227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
    Schwenk J; Makovitzky J
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(6):465-76. PubMed ID: 2499104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic oncofetal antigen and carbohydrate antigen 19-9 in sera of patients with cancer of the pancreas.
    Shahangian S; Fritsche HA; Hughes JI; Gelder FB
    Clin Chem; 1989 Mar; 35(3):405-8. PubMed ID: 2537687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.